4 weeks on tirzepatide no weight loss ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Skipping a Week of Tirzepatide:

These results are consistent with reports that patients treated with semaglutide notice reduced interest in consuming addictive substances including alcohol or tobacco [12]

As demonstrated above, tirzepatide (the active ingredient in Zepbound) appears to lead to greater weight loss than semaglutide (Wegovy) by around 9%

We have launched in the last couple of months, the menopause , perimenopause , and low T , as well as Labs

The FDA also just approved semaglutide for adolescents (ages 12 and up) with an initial BMI at or above the 95th percentile for their age and sex.[ref] Many online telehealth websites now offer GLP-1 medications for weight loss in various forms

By the end of month one, realistic expectations include total weight loss of 3 to 7 pounds (some more, some less), established appetite reduction at the starting dose level, resolved or minimal gastrointestinal side effects, a sense of how your body responds to the medication, and a baseline from which your provider can adjust dosing going forward

Tirzepatide can be effective for weight management in steroid-treated patients, though the metabolic environment created by corticosteroids, including insulin resistance, increased appetite, and altered fat distribution, may affect the magnitude of response